Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Paricalcitol for Severe SHPT in Hemodialysis
NCT03023748Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Sep 2011
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT03023748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023748.